Ophthalmology · Honolulu, HI
NPI
1124169636
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1441 Kapiolani Blvd Ste 1488
Honolulu, HI, 96814
Phone (808) 946-7889
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
2,013 services
Medicare patients, 2024
172
Average age 77
Drug cost, 2024
$1.8M
3,247 prescriptions
Company payments, 2025
$652
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ken C Lin was code 68761 (eye), 610 times for 62 patients. In total Ken C Lin billed 2,013 services in 23 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 68761 Eye | Office | 610 | 62 | $68.88 | $42K |
| 92012 Ophthalmological E&M | Office | 371 | 150 | $68.62 | $25K |
| 92020 Ophthalmological E&M | Office | 160 | 105 | $20.22 | $3,235 |
| 83861 Clinical Chemistry | Office | 157 | 56 | $22.03 | $3,459 |
| 76514 Ultrasound - Nonspecific | Office | 112 | 106 | $7.78 | $871 |
| 92083 Vision, Hearing, and Speech Services | Office | 111 | 91 | $49.90 | $5,539 |
| 92014 Ophthalmological E&M | Office | 99 | 97 | $90.64 | $8,973 |
| 92202 Ophthalmological E&M | Office | 81 | 80 | $11.37 | $921 |
| 92133 Computerized Ophthalmic Imaging | Office | 81 | 81 | $25.93 | $2,101 |
| 92134 Computerized Ophthalmic Imaging | Office | 79 | 59 | $30.92 | $2,442 |
| 67820 Eye | Office | 53 | 34 | $14.50 | $769 |
| 92136 Ultrasound - Nonspecific | Office | 48 | 17 | $17.71 | $850 |
| 92004 Ophthalmological E&M | Office | 12 | 12 | $92.22 | $1,107 |
By year: 2022 $119K for 2,251 services; 2023 $125K for 2,359 services; 2024 $101K for 2,013 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 157 | 56 | $22.03 | $3,459 |
Medicare prescription drug claims, 2024
In 2024, the drug Ken C Lin prescribed most often to Medicare patients was Restasis (Cyclosporine), with 689 prescriptions and refills. In total Ken C Lin wrote 3,247 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 689 | 1,190 | 176 | $766K |
| Erythromycin Erythromycin Base | 436 | 442 | 206 | $6,132 |
| Alphagan P Brimonidine Tartrate | 304 | 537 | 81 | $171K |
| Latanoprost Generic | 272 | 569 | 71 | $4,231 |
| Brimonidine Tartrate Generic | 225 | 430 | 68 | $35K |
| Azelastine Hcl Generic | 151 | 175 | 59 | $5,502 |
| Timolol Maleate Generic | 118 | 204 | 23 | $2,947 |
| Xiidra Lifitegrast | 114 | 165 | 26 | $116K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 111 | 111 | 79 | $1,530 |
| Ofloxacin Generic | 78 | 83 | 50 | $1,561 |
| Diclofenac Sodium Generic | 59 | 60 | 36 | $669 |
| Vyzulta Latanoprostene Bunod | 54 | 72 | 13 | $21K |
| Prednisolone Acetate Generic | 54 | 59 | 42 | $3,750 |
| Brinzolamide Generic | 48 | 63 | Under 11 | $6,988 |
| Xdemvy Lotilaner | 48 | 74 | 44 | $95K |
Brand drugs: 1,922 claims; generic drugs: 1,325 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ken C Lin $652 ($652 in general payments such as food, travel and fees) from 11 companies. The largest payer was Dompe US, Inc. with $152.
| Company | Payments | Amount |
|---|---|---|
| Dompe US, Inc. | 2 | $152 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $93.83 |
| Alcon Vision LLC ALC | 3 | $74.52 |
| Mallinckrodt Hospital Products Inc. | 2 | $62.24 |
| Abbvie Inc. ABBV | 2 | $59.16 |
| Amgen Inc. AMGN | 2 | $54.45 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $52.21 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $31.86 |
| Biotissue Holdings Inc. | 1 | $28.22 |
| Harrow Eye, LLC | 1 | $25.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.